Clinical Trial: Facial Vascularized Composite Allotransplantation: A Study Evaluating Safety, Functional Outcomes, and Patient-Reported Psychosocial Outcomes

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810764) titled 'Facial Vascularized Composite Allotransplantation: A Study Evaluating Safety, Functional Outcomes, and Patient-Reported Psychosocial Outcomes' on Sept. 03.

Brief Summary: The primary objective of this study is to evaluate the 5-year (60-month) allograft survival rate of facial vascularized composite allotransplantation performed under the standardized CONSORT clinical protocol.

Study Start Date: Oct., 2027

Study Type: INTERVENTIONAL

Condition: Facial Vascularized Composite Allotransplantation Functional Recovery

Intervention: PROCEDURE: Facial Vascularized Composite Allotransplantation (VCA)

Facial VCA, performed to treat se...